Home / Inspections / 1287906

FDA Inspection 1287906 — Reese Pharmaceutical Company

Reese Pharmaceutical Company — FEI 1518939

The FDA completed an inspection of Reese Pharmaceutical Company on September 25, 2025 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 25, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cleveland, OH (United States)

Facility

Other inspections at this facility

  • 1160702 (NAI Thu Dec 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1160701 (NAI Wed Dec 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1017672 (NAI Mon Jun 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1012578 (NAI Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 758639 (VAI Wed Jan 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources